Executive readout · one minute
Webcast research workspace
Read the call alongside every captured source. 8-K earnings release, 10-K stay in one workspace.
BCTXL
$0.93
+3.33%
BCTXL
· BriaCell Therapeutics Corp.
$0.93
+0.03 (+3.33%)
At close · Oct 21
Return incl. dividend (before tax)
Going-concern doubt
— flagged Jun 9, 2026
Substantial doubt about the company's ability to continue as a going concern.
“However, the Company's ability to continue as a going concern is dependent upon its ability to attain future profitable operations and to continue to obtain the necessary financing to meet its obligations arising from normal business operations when they come due. The uncertainty of the Company's ability to raise such financial capital casts substantial doubt on the Company's ability to continue as a going concern.”View the 10-Q filed Jun 9, 2026
Market Cap
$31.54M
Shares
8.70M
Volume · Oct 21
17.14K
Avg daily vol (43 sessions)
16.28K
All webcasts
Earnings call · FY2022 Q4
BriaCell Therapeutics Corp. (BCTXL) Q4 2022 Earnings Call
Net income · derived Q4
-$450,352
Research coverage
2 live sources
Open each available source without leaving this research workspace.
Research materials
Open the source you need; every reader stays inside this workspace.
Quarter detail
How the reported period landed and where the business moved.
SEC filing · Item 2.02
8-K earnings release
Filed Oct 28, 2022 · complete as-filed document
SEC periodic report
10-K report
Filed Oct 28, 2022 · complete as-filed document